Sign In
|
Register
|
About Corte Madera
|
Contact Us
Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast
|
Traffic
Corte Madera News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Corte Madera Gas Prices
Ski And Snow Reports
Financial Markets
American
American
Bakery
Asian
Brew Pubs
Bakery/Breakfast
California Cuisine
Coffee Houses
Chinese
Eating Places
Fast Food
Coffee Houses
Delicatessens
German
Fast Food
Greek
Hawaiian
Dessert, Ice Cream and Frozen Yogurt
Italian
Dog Friendly
Italian/Pizza
Jewish
Latin American
Lebanese
Mediterranean
Pizza
Seafood
Soul Food
Sports Bars
Steaks, Chops
Thai
Wine
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Attractions
Nightlife
Family Activities
Arts & Culture
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Air Tours
Amusement & Water Parks
Galleries
General Attractions
Jeep & Hummer Tours
Parks & Preserves
Theatre
Tours
ATV & Hummer Tours
Automotive
Auto Rental
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Motorcycles
Parts & Supplies
Repair & Service
Beauty & Fitness
Barbers
Beauty Salons
Dance Clubs & Studios
Fitness Programs
Health Clubs & Gyms
Weight Loss
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Data Processing Service
Durable Goods
Employment Services, Placement & Agencies
Energy Services
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Graphic Design & Art
Human Resource Services
Management Services
Marketing & Advertising Services
Media Services
Office Furniture, Equipment & Supplies
Office Supplies
Printing & Publishing
Public Relations & Publicity
Research
Security & Investigative Services
Signs & Banners
Staffing & Support Services
Telecommunications
Trucking & Hauling
Video Production
Waste Management & Recycling
Wholesale
Commercial Contractors
Contractors
Architects
Building Contractors & Consultants
Carpentry
Concrete
Drywall, Plastering & Insulation
Electric
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Landscaping
Painting & Wallcovering
Plumbing
Roofing
Special Trade Contractors
Domestic Services
Child Care Services
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Misc. Financial Services
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
State Government
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Mental Health
Nutrition
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Floor Coverings
Furniture
Heating, Cooling & AC
Home Improvement Centers
Lamps & Lighting
Lawn & Garden
Masonry & Stone Work
Nurseries & Garden Centers
Painting & Wallcoverings
Plumbing
Roofing & Siding
Water Supply
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Audio & Visual
Computers, Electronics & Telecommunications
Industrial Supplies & Services
Media
Print Publications
Radio Stations
Television Stations
Meeting & Event Planning
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Live Music
Night Clubs
Personal Service
Barbers, Beauty Salons & Spas
Shoe Repair
Pets
Pet Shops
Pet Supplies & Food - Retail
Training
Veterinary Hospitals
Real Estate
Appraisers
Commercial
Condominiums
Developers
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Brew Pubs
Eating Places
Fast Food
Sports Bars
Steaks, Chops
Wine
Shopping
Accessories
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Convenience Stores
Department Stores
Discount Stores
Electronics
Flowers
Furniture
Gifts & Specialty Shops
Gourmet & Specialty Foods
Grocery Stores
Health Food Stores
Hobbies & Crafts
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Notions
Office Supplies & Service
Pharmacies
Resale Shops
Shoe Stores
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Dance Clubs & Studios, Instruction
Fishing, Fishing Charters and Tours
Golf Courses
Golf Equipment & Supplies
Health Clubs
Instruction
Martial Arts
Recreation Facilities
Sporting Goods
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Auto Rentals
Hotels & Resorts
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Entertainment
Florists
Health & Beauty
Photographers & Videographers
Transportation
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Corte Madera
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
58.12
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Dec 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...
May 06, 2024
From
Bristol Myers Squibb
Via
Business Wire
Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
May 01, 2024
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases
From
Editas Medicine, Inc.
Via
GlobeNewswire
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
April 26, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
April 25, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
April 22, 2024
From
Bristol Myers Squibb
Via
Business Wire
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
April 18, 2024
Via
AB Newswire
Topics
Economy
Exposures
Interest Rates
KRAZATI (adagrasib) in Combination with Cetuximab Demonstrates Clinically Meaningful Activity as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)
April 08, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
April 06, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
April 06, 2024
From
Bristol Myers Squibb
Via
Business Wire
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
April 05, 2024
From
Bristol Myers Squibb
Via
Business Wire
European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)
April 02, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
April 02, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung…
March 28, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Provides Update on the First Phase 3 YELLOWSTONE Trial Evaluating Oral Zeposia (ozanimod) in Patients with Moderate to Severe Active Crohn’s Disease
March 28, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
March 26, 2024
From
Bristol Myers Squibb
Via
Business Wire
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
March 26, 2024
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Bristol Myers Squibb to Present Data at the American College of Cardiology Annual Scientific Session 2024 Reinforcing Extensive Body of Evidence in Clinical and Real-World Settings Across Cardiovascular Portfolio
March 25, 2024
From
Bristol Myers Squibb
Via
Business Wire
Actinium Pharmaceuticals Inc (NYSE:ATNM) Surges on Analyst Upgrade Amidst Radiopharma Sector Momentum
March 22, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Bristol Myers Squibb’s Abecma (idecabtagene vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
March 20, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
March 20, 2024
From
Bristol Myers Squibb
Via
Business Wire
Geron Stock Doubles After Imetelstat Receives FDA Panel Approval
March 20, 2024
Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel
Via
MarketBeat
Exposures
Product Safety
Bristol Myers Squibb and Ted Danson Empower Those with Plaque Psoriasis to Take Action in “SO, Have You Found It?” Campaign
March 19, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
March 18, 2024
From
Bristol Myers Squibb
Via
Business Wire
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
March 15, 2024
From
Bristol Myers Squibb
Via
Business Wire
U.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
March 14, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024
March 11, 2024
From
Bristol Myers Squibb
Via
Business Wire
U.S. Food and Drug Administration Approves Opdivo® (nivolumab), in Combination with Cisplatin and Gemcitabine, for First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
March 07, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
March 06, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Announces Dividend
March 01, 2024
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Announces New Data from the Long-Term DAYBREAK Study Reinforcing Efficacy and Safety of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis
February 29, 2024
From
Bristol Myers Squibb
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.